PanGenex Finalizes Acquisition of Calgenex Corporation
PanGenex Corporation (Pink Sheets:PGXC) announces that on April 8th, 2008, the Company completed the acquisition of Calgenex Corporation. Calgenex develops and markets proprietary formulations to address specific health conditions. Calgenex has developed a line of nutraceuticals including Calci-CLEAR(TM) to address soft tissue calcification, Omeganol to encourage cholesterol balancing and the topical application Dermalleve for psoriasis, eczema and dermatitis.
TAMPA, Fla. (PRWEB) April 21, 2008
"Completing the acquisition of Calgenex allows us to aggressively begin marketing our proprietary nutraceutical product line through the internet, physician referrals and other retail platforms. In the near future we will be welcoming very prestigious physicians to both our Board of Directors and Scientific Advisory Board as we strive to make a lasting impact throughout the cardiovascular health industry," stated Jeff Roman, CEO and President of PanGenex Corporation.
Calgenex was acquired for 22M shares of restricted common stock. Further corporate updates and additional information are available on the Company website at www. PanGenex. com and www. PinkSheets. com.
About PanGenex Corporation
PanGenex pursues business opportunities in the nutraceutical and cardiovascular health industries. The Company seeks to develop and market novel, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Healthy Solutions from Science and Nature.(TM)
Learn more about Calgenex by visiting: www. Calgenex. com
Disclaimer:
Cautionary Statement about Forward-Looking Statements
This press release contains "forward-looking statements," which are statements related to future, not past, events. In this context, the forward-looking statements often include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future acquisitions and business strategy, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "seeks" or "will." Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and business conditions, (b) the level of strategic partner incentives, (c) the future regulatory environment, (d) our cost of financing, (e) our ability to complete acquisitions and dispositions and the risks associated therewith, and (f) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook.
